Self-monitoring of blood glucose: Advice for providers and patients

Cleveland Clinic Journal of Medicine

Volumn 83, Issue 5, 2016, Pages 355-360

  Knapp, Shannon ^a   Manroa, Pooja ^b   Doshi, Krupa ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD GLUCOSE MONITORING; DECISION MAKING; DIABETES MELLITUS; DISEASE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH EDUCATOR; HUMAN; PROCEDURES; PSYCHOLOGY; SELF CARE;

BLOOD GLUCOSE SELF-MONITORING; DECISION MAKING; DIABETES MELLITUS; DISEASE MANAGEMENT; HEALTH EDUCATORS; HEALTH PERSONNEL; HUMANS; SELF CARE;

EID: 84984653506     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.83a.14147     Document Type: Review

References (12)

1. Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011; 34:262-267.
2. American Diabetes Association (ADA). Standards of medical care in diabetes-2016. Glycemic targets. Diabetes Care 2016; 39(suppl):S39-S46.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
4. Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653.
5. International Diabetes Federation (IDF). IDF guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes. www.idf.org/guidelines/self-monitoring. Accessed April 8, 2016.
6. Bosi E, Scavini M, Ceriello A, et al; PRISMA Study Group. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 2013; 36:2887-2894.
7. Franciosi M, Lucisano G, Pellegrini F, et al; ROSES Study Group. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 2011; 28:789-796.
8. Durán A, Martín P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2010; 2:203-211.
9. Kempf K, Kruse J, Martin S. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther 2010; 12:547-553.
10. Wahowiak L; American Diabetes Association (ADA). Blood glucose meters 2014. www.diabetesforecast.org/2014/Jan/blood-glucose-meters-2014.html. Accessed April 10, 2016.
11. International Organization for Standardization (ISO). ISO 15197:2013. In vitro diagnostic test systems-requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. www.iso.org/obp/ui/#iso:std:iso:15197:ed-2:v1:en. Accessed April 8, 2016.
12. Ramljak S, Lock JP, Schipper C, et al. Hematocrit interference of blood glucose meters for patient self-measurement. J Diabetes Sci Technol 2013; 7:179-189.